14 February 2022

Haematologists in Europe have compiled the first ever open access handbook on the use of CAR-T cell therapy. The handbook has been drawn together by the European Hematology Association (EHA) and the European Society for Blood and Marrow Transplantation (EBMT).

The EBMT/EHA CAR-T Cell Handbook” covers the science behind the treatment, indications for therapy, management of side-effects, and access and manufacturing issues.

EBMT President Professor Nicolaus Kröger said: “The launch of the CAR-T Cell handbook reflects the truly collaborative achievement across EBMT and EHA. This demonstrates once again that putting our experience and competencies in common, we can enhance our education goals and ultimately improve the care of our patients.”

Professor Christian Chabannon, Chair of the EBMT Cellular Therapy and Immunobiology Working Party, added: “This handbook reaches the objective to provide an overview of the CAR-T technology and the readers, physicians and nurses, will find real application in clinical care”.

EHA Past President Professor John Gribben said: “The EHA-EBMT handbook will serve as a vital resource for those working on the CART field in Europe and provides another wonderful example of how the collaboration between EBMT and EHA continues to enhance the field of CART research and clinical development in Europe.”

Professor Hermann Einsele, chair of the EHA’s scientific workshop group immunotherapy of haematological malignancies, said: “This handbook will be a very important tool to educate and motivate young scientists, medical doctors, technicians and nurses to engage in this novel and promising treatment strategy.”

Source: EMBT

Link: https://link.springer.com/book/9783030943547

Disclaimer: The news stories shared on this site are used as a way to inform our members and followers of updates and relevant information happening in Haematology. The BSH does not endorse the content of news items from external sources, and is not in a position to verify the findings, accuracy or the source of any studies mentioned. Any medical or drugs information is provided as an information resource only, and is not to be relied on for any diagnostic or treatment purposes.

News service provided by Englemed News http://www.englemed.co.uk/